PECS II Versus ICBN Block Plus SCNB for AV Fistula Creation in CRF Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Intraoperative AnalgesiaPostoperative Pain
Interventions
OTHER

ultrasUltrasound-guided Intercostobrachial nerve block supplemental to supraclavicular block with 30 ml 0.25% bupivacaine (15 ml 0.5% bupivacaine will be added to 15 m

patients recieved ultrasound-guided Intercostobrachial nerve block with 10 ml 0.25% bupivacaine (5 ml 0.5% bupivacaine will be added to 5ml 0.9% normal saline ) supplemental to supraclavicular block with 30 ml 0.25% bupivacaine (15 ml 0.5% bupivacaine will be added to 15 ml of 0.9 %Nacl ) .

OTHER

ultrasound-guided pectoral nerves block type II supplemental to supraclavicular block

Patients received ultrasound-guided pectoral nerves block type II with 10 ml 0.25% bupivacaine (5 ml 0.5% bupivacaine will be added to 5ml 0.9% normal saline ) supplemental to supraclavicular block with 30 ml 0.25% bupivacaine (15 ml 0.5% bupivacaine will be added to 15 ml of 0.9 %Nacl )

Trial Locations (1)

32951

Ashraf Magdy Eskandr, Shibīn al Kawm

All Listed Sponsors
collaborator

Mamdoh Elsayed Lotfy

UNKNOWN

collaborator

amany aly sultan

UNKNOWN

collaborator

reem gaber abdel-mageed

UNKNOWN

lead

Menoufia University

OTHER

NCT04988776 - PECS II Versus ICBN Block Plus SCNB for AV Fistula Creation in CRF Patients | Biotech Hunter | Biotech Hunter